Long-term outcome of treating rheumatoid arthritis: results after 20 years.
about
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systematic review.Imaging of joints with laser-based photoacoustic tomography: an animal study.Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data.What should we hope to achieve when treating rheumatoid arthritis?Measuring performance in clinical rheumatology.Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.Treatment of early rheumatoid arthritis with rifampicin.Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritisIn vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitor.Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patientsEarly rheumatoid arthritis: time to aim for remission?A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature.The surgical management of the rheumatoid spine: Has the evolution of surgical intervention changed outcomes?The links between joint damage and disability in rheumatoid arthritis.Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries.Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsComparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.Combination therapy for autoimmune diseases: the rheumatoid arthritis model.A history of the term "DMARD".A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiatedThe validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study.Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritisOnly high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategyContribution of patient related differences to multidrug resistance in rheumatoid arthritis.Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.Rheumatoid arthritis in 2003: where are we now with treatment?Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritisPrognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trialCoverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.Lower limb joint replacement in rheumatoid arthritis.Unmet needs in rheumatoid arthritis.
P2860
Q24817087-BC73D2CD-C3EA-437F-85AA-DEF96D3E41F9Q30251996-4BB275D2-51AA-43A9-93E5-B51E6551E5C6Q33257029-11114090-4488-4D65-A57B-CE0D3A350F84Q33561006-FE1227EA-F0BB-42A7-88B3-6CAA50AD6B5DQ33561548-2B2F5B03-5B58-430C-9246-DE76CE399543Q33562244-3CF71507-611A-410A-B67A-E7C79BF895D0Q33562682-C58EEDCB-D172-46B2-B8D4-0ACBD93AEAABQ33564192-15702187-9CA3-4FF1-B10D-6B1E8CCA6F1DQ33566728-1E09E6B2-154F-44F4-8EA4-8F959BA7BF1BQ33578246-196FDFDC-7814-45CC-B5EE-C29E33833F02Q33578492-84A5BB16-EF35-4146-8D6F-086201AA5004Q33578559-19979839-DF02-45E7-88A7-89CD3ABA21E3Q33578782-AF18EBB6-6C27-4E31-85DC-F0FC84036473Q33831409-54C7D6AC-0AFF-4289-BAFC-29971F2CA155Q33859931-9F95F961-EEC6-499B-BC82-C2AA2625035CQ33867923-AAEC7492-2338-47A7-86C8-4B94494BD614Q33910506-6E57A97D-D9F4-4E7E-8693-534BC17F686BQ34076916-BD997614-4F7E-4A03-85FB-9713FE635513Q34082035-37C1062D-CD92-4A6B-B0D6-966D6B247A5CQ34110066-C1F80666-5031-4A26-B401-13C42945E3C9Q34124686-F55D9627-FA22-46C6-B8A6-15F8B9F54000Q34264322-7767C2E8-B369-4C30-9547-79D56BCF1F48Q34309751-DB7F9D7F-DC0D-495D-A120-A351246B9D0DQ34477556-7D2A0A29-EB96-4C19-B6E9-136E3B345D15Q34486243-D1D75110-6ADD-4472-BD27-F86CA6B5793BQ34897125-9B2C8706-3CF7-42A7-B0BF-C8C9A669226EQ35074573-D672879E-FB77-44CA-8D06-7FB663D2C683Q35092914-871D5F79-F2C7-45B1-B370-883D75DB8FE0Q35548151-B8E094B0-5052-47FB-871C-33909B42A227Q35551965-B06F35F8-66AD-4403-B376-24C7485B8880Q35552265-C24CCB27-24EA-4D96-A530-EAF595D03B7EQ35553548-C1D2559A-77D4-445A-BC68-E33DADFC1A85Q35553932-2AE8FB74-41A3-49E7-A055-07D094F2260FQ35554180-ED2C75A2-9AE1-40A1-A0BD-32C18E85E391Q35555021-612A3085-02F9-4B60-ACE7-077157A09CACQ35562353-C52BF40E-DD2E-4E83-A60E-57BEB366EA3DQ35731438-8BE7FCEB-A636-4EC5-A9AC-47DF82DFB5D4Q36013828-40168DE6-572D-42CE-A06F-1FDCEA1A0B6DQ36138807-6DA065EC-9AE7-448A-AD7A-94DF81AD3B15Q36165321-0BE5162B-F9CB-4599-A3FB-CFBA42677C3C
P2860
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
@en
type
label
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
@en
prefLabel
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
@en
P2093
P1433
P1476
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
@en
P2093
A J Popert
B L Coulton
D P Symmons
P304
P356
10.1016/S0140-6736(87)91672-2
P407
P577
1987-05-01T00:00:00Z